Skip to main content
Mari AS Cayabyab on Muck Rack

Mari AS Cayabyab

As seen in: Wiley Online Library, Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mari AS

Contact Mari AS, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

A call for reporting of tumor‐specific outcomes in studies of DPYD genotyping

|
By Mari AS Cayabyab, Glenda Hoffecker, Sony Tuteja, Victoria Wittner
| Wiley Online Library Verified
We read with great interest the findings published in your journal by Muldoon et al. of real-world implementation of DPYD and UGT1A1 pharmacogenetic testing in a community-based cancer center1 and would like to share some comments regarding the need for specifically reporting outcomes by tumor type. Most existing studies focus on preemptive DPYD genotyping for fluoropyrimidines in gastrointestinal cancers, rarely are outcomes reported for breast cancer.
Open in Who Shared Issue with article?

Precision medicine: a call for increased pharmacogenomic education

|
By Richard Ta, Mari AS Cayabyab, Rodolfo Coloso, Daryl E Pritchard
| Future Medicine Verified
Metrics Downloaded 38 times History Received 5 September 2018 Accepted 30 January 2019 Published online 26 April 2019 Information © 2019 Future Medicine Ltd KeywordsAcknowledgments We would like to thank E Kim for the opportunity to share our perspective, and A Liu for support and supplemental review of the manuscript; we sincerely appreciate your efforts.
Open in Who Shared Issue with article?
See all 2 articles